- Home•
- IHC & ISH•
- IHC Primary Antibodies•
- CD20
CD20
Product Specific Information
CCD20は、約33kDの非グリコシル化リン酸化タンパクです。正常および悪性のヒトB細胞に発現しており、B細胞の活性化と分化において受容体として機能すると考えられています。CD20は、末梢血の正常B細胞、リンパ節、脾臓、扁桃、骨髄、急性白血病および慢性リンパ性白血病に発現すると報告されています。
Disclaimer
CD20 is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using non-immunologic histochemical stains.
Products
Products
This Material is Available for Sale In:
Andorra
Australia
Austria
Belgium
Brunei Darussalam
Canada
Denmark
Finland
France
French Guiana
Germany
Guadeloupe
Holy See (Vatican City State)
Hong Kong
Ireland
Italy
Japan
Liechtenstein
Luxembourg
Malaysia
Martinique
Myanmar
Netherlands
New Caledonia
New Zealand
Norway
Philippines
Portugal
Reunion
Singapore
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
United Kingdom
Vietnam
This Material is Available for Sale In:
China
This Material is Available for Sale In:
Andorra
Australia
Austria
Belgium
Brunei Darussalam
Canada
China
Denmark
Finland
France
French Guiana
Germany
Guadeloupe
Holy See (Vatican City State)
Hong Kong
Indonesia
Ireland
Italy
Japan
Liechtenstein
Luxembourg
Malaysia
Martinique
Myanmar
Netherlands
New Caledonia
New Zealand
Norway
Philippines
Portugal
Reunion
Singapore
South Korea
Spain
Sweden
Switzerland
Thailand
United Kingdom
Vietnam
This Material is Available for Sale In:
Andorra
Australia
Austria
Belgium
Brunei Darussalam
Canada
China
Denmark
Finland
France
French Guiana
Germany
Guadeloupe
Holy See (Vatican City State)
Hong Kong
Indonesia
Ireland
Italy
Japan
Liechtenstein
Luxembourg
Martinique
Netherlands
New Caledonia
New Zealand
Norway
Philippines
Portugal
Reunion
Spain
Sweden
Switzerland
Thailand
United Kingdom
Vietnam
This Material is Available for Sale In:
Australia
Austria
Belgium
Brunei Darussalam
Canada
China
Denmark
Finland
France
French Guiana
Germany
Guadeloupe
Holy See (Vatican City State)
Hong Kong
Ireland
Italy
Japan
Liechtenstein
Luxembourg
Martinique
Netherlands
New Caledonia
New Zealand
Norway
Philippines
Portugal
Reunion
Singapore
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
United Kingdom
Vietnam